Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cancer gene therapy: challenges and opportunities.

Kevin J Scanlon1

  • 1Keck Graduate Institute, 535 Watson Dr., Claremont, CA 91711, USA. kevin_scanlon@kgi.edu

Anticancer Research
|May 22, 2004
PubMed
Summary

Gene therapy faces delivery challenges, with future success depending on advances in viral and non-viral vectors, nanoparticles, and other technologies for effective cancer treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Commercializing medical technology.

Cytotechnology·2008
Same author

Anti-genes: siRNA, ribozymes and antisense.

Current pharmaceutical biotechnology·2004
Same author

Construction and transfection of a ribozyme targeting human caspase-3.

Anticancer research·2004
Same author

Ribozyme against mutant K-ras mRNA suppresses tumor growth of pancreatic cancer.

International journal of oncology·2004
Same author

Reversal of drug resistance using hammerhead ribozymes against multidrug resistance-associated protein and multidrug resistance 1 gene.

International journal of oncology·2002

Area of Science:

  • Molecular medicine and biotechnology
  • Therapeutic strategies for human diseases

Background:

  • Human disease understanding relies on molecular basis for targeted therapies.
  • Cell and protein therapies have historical precedence.
  • Gene therapy represents a novel therapeutic frontier.

Purpose of the Study:

  • To explore the future trajectory of gene therapy over the next five years.
  • To identify key challenges and advancements in gene therapy, particularly for cancer.
  • To assess the evolution of gene delivery systems.

Main Methods:

  • Review of current gene therapy advancements.
  • Analysis of challenges in gene delivery (ex vivo vs. systemic).
  • Discussion of viral, non-viral, and nanoparticle vector technologies.

Main Results:

  • Delivery of efficacious gene doses to target tissues remains the primary challenge.
  • The field is exploring a shift from ex vivo to systemic delivery methods.
  • Non-viral vectors and nanoparticles show promise for future gene delivery.

Conclusions:

  • Gene therapy's future success hinges on integrating progress from diverse fields like nanotechnology and medical devices.
  • Overcoming delivery hurdles is crucial for realizing gene therapy's potential, especially in oncology.
  • Continued innovation in vector technology is essential for widespread clinical application.

Related Experiment Videos